SPARSH BIOTECH is rapidly establishing itself as a key player in the pharmaceutical sector, especially recognized for its cutting-edge process of manufacturing Amoxicillin and Augmentin. The organization boasts sophisticated infrastructure and a dedicated team guaranteeing high-quality drugs reaching patients international